scholarly journals Oral Propranolol: A Useful Treatment for Infantile Hemangioma

2015 ◽  
Vol 08 (07) ◽  
pp. 441-450
Author(s):  
Ahmed Hassan El-Sabbagh
Keyword(s):  
Infantile Hemangioma ◽  
Oral Propranolol

scholarly journals The effectiveness of oral propranolol for infantile hemangioma on the head and neck region: A case series

2021 ◽  
pp. 106120
Author(s):  
Prasetyanugraheni Kreshanti ◽  
Nandya Titania Putri ◽  
Valencia Jane Martin ◽  
Chaula Luthfia Sukasah
Keyword(s):  
Head And Neck ◽  
Case Series ◽  
Neck Region ◽  
Infantile Hemangioma ◽  
Head And Neck Region ◽  
Oral Propranolol

scholarly journals Efficacy and safety of oral propranolol for infantile hemangioma in Japan

2017 ◽  
Vol 59 (8) ◽  
pp. 869-877 ◽  
Author(s):  
Tsuyoshi Kaneko ◽  
Satoru Sasaki ◽  
Naoko Baba ◽  
Katsuyoshi Koh ◽  
Kiyoshi Matsui ◽  
...  
Keyword(s):  
Infantile Hemangioma ◽  
Efficacy And Safety ◽  
Oral Propranolol

scholarly journals Effects of Propranolol on Neurodevelopmental Outcomes in Patients with Infantile Hemangioma: A Case-Control Study

2018 ◽  
Vol 2018 ◽  
pp. 1-6
Author(s):  
Chuan Wang ◽  
Qi Wang ◽  
Bo Xiang ◽  
Siyuan Chen ◽  
Fei Xiong ◽  
...  
Keyword(s):  
Treatment Duration ◽  
Infantile Hemangioma ◽  
Control Group ◽  
Healthy Children ◽  
Neurodevelopmental Outcomes ◽  
Obvious Effect ◽  
Negative Effect ◽  
Initiation Of Therapy ◽  
Propranolol Therapy ◽  
Oral Propranolol

Background. The aim of this study was to examine whether oral propranolol has any effect on neurodevelopment outcomes in young children with problematic infantile hemangiomas (IHs). Methods. Thirty-six children with a diagnosis of problematic IH who were treated with oral propranolol were compared with 34 healthy children with no history of propranolol therapy. Patients received propranolol therapy for at least 3 months. Gesell developmental schedules (GDS) were used to evaluate neurodevelopment outcomes in the two groups. The scores of each GDS domain were compared between the two groups. Results. There were no significant differences in developmental quotient (DQ) values for any of the five domains between the patients and healthy controls (P<0.05). Multiple stepwise regression analyses showed that none of the domains in the control group were influenced by the children’s gender or age (P<0.05). In addition, we found that gender, age at the initiation of therapy, age at the time of the neurodevelopment test, and treatment duration had no effect on any domain of the GDS in the patient group (P>0.05). Conclusion. Propranolol has no obvious effect on neurodevelopmental outcomes in children. Early treatment and treatment duration had no negative effect on central nervous system (CNS) development.

Clinical and radiological outcomes of infantile hemangioma treated with oral propranolol: A long‐term follow‐up study

2019 ◽  
Vol 46 (5) ◽  
pp. 376-382
Author(s):  
Zhang Yu ◽  
Ren Cai ◽  
Lei Chang ◽  
Yajing Qiu ◽  
Xuanfeng Chen ◽  
...  
Keyword(s):  
Infantile Hemangioma ◽  
Follow Up Study ◽  
Long Term Follow Up ◽  
Oral Propranolol

scholarly journals A Randomized Controlled Trial of Oral Propranolol in Infantile Hemangioma

2015 ◽  
Vol 62 (2) ◽  
pp. 518-519 ◽  
Author(s):  
C. Léauté-Labréze ◽  
P. Hoeger ◽  
J. Mazereeuw-Hautier
Keyword(s):  
Randomized Controlled Trial ◽  
Controlled Trial ◽  
Infantile Hemangioma ◽  
Randomized Controlled ◽  
Oral Propranolol

Safety of Oral Propranolol for the Treatment of Infantile Hemangioma: A Systematic Review

PEDIATRICS ◽  
2016 ◽  
Vol 138 (4) ◽  
pp. e20160353-e20160353 ◽  
Author(s):  
C. Leaute-Labreze ◽  
O. Boccara ◽  
C. Degrugillier-Chopinet ◽  
J. Mazereeuw-Hautier ◽  
S. Prey ◽  
...  
Keyword(s):  
Systematic Review ◽  
Infantile Hemangioma ◽  
Oral Propranolol

A Randomized, Controlled Trial of Oral Propranolol in Infantile Hemangioma

2015 ◽  
Vol 372 (8) ◽  
pp. 735-746 ◽  
Author(s):  
Christine Léauté-Labrèze ◽  
Peter Hoeger ◽  
Juliette Mazereeuw-Hautier ◽  
Laurent Guibaud ◽  
Eulalia Baselga ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Controlled Trial ◽  
Infantile Hemangioma ◽  
Randomized Controlled ◽  
Oral Propranolol
Sign in / Sign up

Export Citation Format

Share Document